3 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Kanamycin: new trials by email Literature Review of Kanamycin trials Research Report on Kanamycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine - MDR-TB | Phase 3 | Completed | IUATLD, Inc | 588 | 2016-03-01 | 2023-09-28 |
| An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis Linezolid, Bedaquiline, Levofloxacin - Tuberculosis, Multidrug Resistant Tuberculosis | Phase 2 / Phase 3 | Completed | University of Cape Town | 154 | 2015-11-12 | 2021-09-29 |
| Trial of Antibiotic Prophylaxis in Elective Laparoscopic Colorectal Surgery: Oral and Systemic Versus Systemic Antibiotics cefmetazole, kanamycin/metronidazole - Colorectal Neoplasms | Phase 3 | Completed | Japan Multinational Trial Organization | 584 | 2007-09-01 | 2012-09-19 |
Tuberculosis, Multidrug-Resistant (2) · Colorectal Neoplasms (1) · Extensively Drug-Resistant Tuberculosis (1) · Tuberculosis (1)
IUATLD, Inc (1) · Japan Multinational Trial Organization (1) · University of Cape Town (1)
South Africa (2) · Ethiopia (1) · Georgia (1) · India (1) · Japan (1) · Moldova (1) · Mongolia (1) · Uganda (1)
Andrew Nunn, PhD (1) · Hiroaki Hata, MD (1) · Keertan Dheda, MBChB (1) · Sarah Meredith, MD (1)
PMID 26929418, PMID 30865791, PMID 31932382, PMID 35175905, PMID 38462751